Concepedia

Xingpan Song

XS

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2022

Affiliations

Wuhan YZY Biopharma (China)(Current)

Xingpan Song is an author at Wuhan YZY Biopharma (China) specializing in tumor-associated antigen targeting, bispecific antibody therapy, and low-toxicity reagents.

Publications per year

2022–2022

1

Publications

1

Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell

Rui Yang, Qing He, Hui Zhou et al. · Frontiers in Immunology · 2022 · 10 citations · Full text

, , +17

1–1 of 1